NEW YORK, Nov. 14 – Belgian functional genomics company Galapagos Genomics said Wednesday that it had agreed to build a gene library for Pharmacia designed to help the pharmaceutical company to identify and validate drug targets for a range of diseases.

Galapagos has developed the PhenoSelect expression platform, which uses arrayed adenoviruses containing human genes to identify and validate targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.